Paul M. Silber

841 total citations
20 papers, 679 citations indexed

About

Paul M. Silber is a scholar working on Pharmacology, Oncology and Hepatology. According to data from OpenAlex, Paul M. Silber has authored 20 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 5 papers in Oncology and 4 papers in Hepatology. Recurrent topics in Paul M. Silber's work include Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (5 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Paul M. Silber is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (5 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Paul M. Silber collaborates with scholars based in United States, Canada and Switzerland. Paul M. Silber's co-authors include Albert P. Li, Peter J. O’Brien, Chuang Lu, Charles E. Ruegg, Katie Chan, Nicola J. Hewitt, Scott A. Lloyd, A. Jay Gandolfi, Klaus Brendel and Neil S. Jensen and has published in prestigious journals such as Analytical Biochemistry, Biochemical Pharmacology and Cancer Letters.

In The Last Decade

Paul M. Silber

20 papers receiving 621 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Paul M. Silber 359 203 177 130 100 20 679
María José Gómez Lechón 252 0.7× 154 0.8× 153 0.9× 208 1.6× 127 1.3× 7 587
Brigitte Gerin 215 0.6× 132 0.7× 226 1.3× 177 1.4× 144 1.4× 11 761
B. O. Depelchin 176 0.5× 88 0.4× 266 1.5× 169 1.3× 144 1.4× 7 714
Anna-Karin Sohlenius-Sternbeck 282 0.8× 212 1.0× 171 1.0× 70 0.5× 30 0.3× 22 594
Thomas K. Baker 130 0.4× 109 0.5× 335 1.9× 78 0.6× 100 1.0× 28 818
Malin Darnell 220 0.6× 99 0.5× 162 0.9× 191 1.5× 217 2.2× 15 564
Teija Oinonen 233 0.6× 117 0.6× 282 1.6× 100 0.8× 52 0.5× 19 699
Franck A. Atienzar 243 0.7× 97 0.5× 327 1.8× 208 1.6× 204 2.0× 12 913
Charles E. Ruegg 177 0.5× 120 0.6× 155 0.9× 67 0.5× 50 0.5× 12 469
Cornelia M. Smith 258 0.7× 126 0.6× 110 0.6× 53 0.4× 34 0.3× 7 574

Countries citing papers authored by Paul M. Silber

Since Specialization
Citations

This map shows the geographic impact of Paul M. Silber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul M. Silber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul M. Silber more than expected).

Fields of papers citing papers by Paul M. Silber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul M. Silber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul M. Silber. The network helps show where Paul M. Silber may publish in the future.

Co-authorship network of co-authors of Paul M. Silber

This figure shows the co-authorship network connecting the top 25 collaborators of Paul M. Silber. A scholar is included among the top collaborators of Paul M. Silber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul M. Silber. Paul M. Silber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bachmann, Kenneth, Heather Eng, Donald B. White, et al.. (2007). An Estimate of the Number of Hepatocyte Donors Required to Provide Reasonable Estimates of Human Hepatic Clearance from In Vitro Experiments. Drug Metabolism Letters. 1(2). 91–95. 1 indexed citations
2.
Chan, Katie, Neil S. Jensen, Paul M. Silber, & Peter J. O’Brien. (2006). Structure–activity relationships for halobenzene induced cytotoxicity in rat and human hepatoctyes. Chemico-Biological Interactions. 165(3). 165–174. 37 indexed citations
3.
Li, Li, Todd D. Porter, Neil S. Jensen, et al.. (2006). NEW CYTOCHROME P450 2D6*56 ALLELE IDENTIFIED BY GENOTYPE/PHENOTYPE ANALYSIS OF CRYOPRESERVED HUMAN HEPATOCYTES. Drug Metabolism and Disposition. 34(8). 1411–1416. 12 indexed citations
4.
Blanchard, Nadège, Nicola J. Hewitt, Paul M. Silber, et al.. (2006). Prediction of hepatic clearance using cryopreserved human hepatocytes: a comparison of serum and serum-free incubations. Journal of Pharmacy and Pharmacology. 58(5). 633–641. 50 indexed citations
5.
Kondo, Hiroko, Hiroshi Fujisaki, Genfu Chen, et al.. (2004). O-24 Independent regulation of intrarenal angiotensin receptors expression during the development of cyclosporine A-induced hypertension(KIDNEYS AND URINARY EXCRETION SYSTEM)(GENERAL SESSION BY ORAL PRESENTATION)(Proceedings of the 31st Annual Meeting). The Journal of Toxicological Sciences. 29(4). 404. 2 indexed citations
6.
Goodman, Julie E., et al.. (2004). Catechol-O-methyltransferase low activity genotype (COMTLL) is associated with low levels of COMT protein in human hepatocytes. Cancer Letters. 214(2). 189–195. 25 indexed citations
7.
O’Brien, Peter J., Katie Chan, & Paul M. Silber. (2004). Human and animal hepatocytes in vitro with extrapolation in vivo. Chemico-Biological Interactions. 150(1). 97–114. 75 indexed citations
8.
Roymans, Dirk, Angelique M. Leone, J. Brandon Parker, et al.. (2003). Determination of cytochrome P450 1A2 and cytochrome P450 3A4 induction in cryopreserved human hepatocytes. Biochemical Pharmacology. 67(3). 427–437. 57 indexed citations
9.
Arterburn, Linda M., et al.. (2003). MAINTENANCE OF LIVER FUNCTIONS IN RAT HEPATOCYTES CULTURED AS SPHEROIDS IN A ROTATING WALL VESSEL. In Vitro Cellular & Developmental Biology - Animal. 39(1). 13–13. 36 indexed citations
10.
Nicolau, G., et al.. (2003). P.1.048 Metabolism phenotype and in vitro drug-drug interaction studies with nemifitide, a novel pentapeptide antidepressant. European Neuropsychopharmacology. 13. S194–S195. 1 indexed citations
11.
Lloyd, Scott A., et al.. (2002). Differential in vitro hepatotoxicity of troglitazone and rosiglitazone among cryopreserved human hepatocytes from 37 donors. Chemico-Biological Interactions. 142(1-2). 57–71. 37 indexed citations
12.
Prabhu, Saileta, et al.. (2002). Identification of glutathione conjugates of troglitazone in human hepatocytes. Chemico-Biological Interactions. 142(1-2). 83–97. 49 indexed citations
13.
Silber, Paul M., et al.. (2002). A PERFUSED ROTATING WALL VESSEL BIOARTIFICIAL LIVER. ASAIO Journal. 48(2). 196–196. 1 indexed citations
14.
15.
Gettings, S.D., D.M. Bagley, Paul I. Feder, et al.. (1990). The CTFA evaluation of alternatives program: an evaluation of In vitro alternatives to the draize primary eye irritation test (phase I) hydro-alcoholic formulations; a preliminary communication. Europe PMC (PubMed Central). 3(4). 293–302. 21 indexed citations
16.
Silber, Paul M., Thomas Stephens, & Otto H. Mills. (1989). On the comedogenic potential of quaternium-15 and DMDM hydantoin. Journal of the Society of Cosmetic Chemists. 40(3). 135–139. 1 indexed citations
17.
Silber, Paul M., et al.. (1989). Comparative Skin Irritation of High and Low Spf Sunscreen Products. Journal of Toxicology Cutaneous and Ocular Toxicology. 8(4). 555–563. 1 indexed citations
18.
Stephens, Thomas, et al.. (1989). Localized Eye Area Sensitivity Syndrome. Journal of Toxicology Cutaneous and Ocular Toxicology. 8(4). 569–570. 1 indexed citations
19.
Silber, Paul M., A. Jay Gandolfi, & Klaus Brendel. (1986). Adaptation of a γ-glutamyl transpeptidase assay to microtiter plates. Analytical Biochemistry. 158(1). 68–71. 25 indexed citations
20.
Silber, Paul M., A. Jay Gandolfi, & Klaus Brendel. (1986). Early Biological Indicators of S-(1,2-Dichlorovinyl)-L-Cysteine Nephrotoxicity in the Rabbit. Drug and Chemical Toxicology. 9(3-4). 285–303. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María José Gómez Lechón Breakdown of academic impact, for papers by Brigitte Gerin Breakdown of academic impact, for papers by B. O. Depelchin Breakdown of academic impact, for papers by Anna-Karin Sohlenius-Sternbeck Breakdown of academic impact, for papers by Thomas K. Baker Breakdown of academic impact, for papers by Malin Darnell Breakdown of academic impact, for papers by Teija Oinonen Breakdown of academic impact, for papers by Franck A. Atienzar Breakdown of academic impact, for papers by Charles E. Ruegg Breakdown of academic impact, for papers by Cornelia M. Smith
Rankless by CCL
2026